HK1012366A1 - Process for the preparation of cyano-methoxyiminomethyl derivatives - Google Patents

Process for the preparation of cyano-methoxyiminomethyl derivatives

Info

Publication number
HK1012366A1
HK1012366A1 HK98113520A HK98113520A HK1012366A1 HK 1012366 A1 HK1012366 A1 HK 1012366A1 HK 98113520 A HK98113520 A HK 98113520A HK 98113520 A HK98113520 A HK 98113520A HK 1012366 A1 HK1012366 A1 HK 1012366A1
Authority
HK
Hong Kong
Prior art keywords
methoxyiminomethyl
cyano
derivatives
preparation
formula
Prior art date
Application number
HK98113520A
Other languages
English (en)
Inventor
Mark Jason Hughes
John Kitteringham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1012366A1 publication Critical patent/HK1012366A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98113520A 1992-02-20 1998-12-15 Process for the preparation of cyano-methoxyiminomethyl derivatives HK1012366A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process
PCT/GB1993/000291 WO1993017018A1 (en) 1992-02-20 1993-02-11 Nitrosation process

Publications (1)

Publication Number Publication Date
HK1012366A1 true HK1012366A1 (en) 1999-07-30

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113520A HK1012366A1 (en) 1992-02-20 1998-12-15 Process for the preparation of cyano-methoxyiminomethyl derivatives

Country Status (19)

Country Link
US (2) US5545740A (xx)
EP (2) EP0984008A3 (xx)
JP (1) JP3288704B2 (xx)
KR (1) KR100261530B1 (xx)
AT (1) ATE194341T1 (xx)
AU (1) AU669355B2 (xx)
CA (1) CA2131019C (xx)
DE (1) DE69328962T2 (xx)
DK (1) DK0626961T3 (xx)
ES (1) ES2147749T3 (xx)
GB (1) GB9203688D0 (xx)
GR (1) GR3034295T3 (xx)
HK (1) HK1012366A1 (xx)
MX (1) MX9300875A (xx)
NZ (1) NZ246940A (xx)
PT (1) PT626961E (xx)
TW (1) TW224466B (xx)
WO (1) WO1993017018A1 (xx)
ZA (1) ZA931132B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
JP2002503224A (ja) * 1997-04-11 2002-01-29 エリ リリー アンド カンパニー 疼痛を処置するための組成物
AU7107998A (en) * 1997-04-11 1998-11-11 Eli Lilly And Company Method for treating schizophrenia
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
ES2147749T3 (es) 2000-10-01
TW224466B (xx) 1994-06-01
DK0626961T3 (da) 2000-11-06
GR3034295T3 (en) 2000-12-29
EP0984008A2 (en) 2000-03-08
ATE194341T1 (de) 2000-07-15
AU669355B2 (en) 1996-06-06
ZA931132B (en) 1993-10-14
EP0626961A1 (en) 1994-12-07
MX9300875A (es) 1993-08-31
US6596869B2 (en) 2003-07-22
AU3460793A (en) 1993-09-13
GB9203688D0 (en) 1992-04-08
KR950700292A (ko) 1995-01-16
US20020143185A1 (en) 2002-10-03
WO1993017018A1 (en) 1993-09-02
JPH07504180A (ja) 1995-05-11
US5545740A (en) 1996-08-13
JP3288704B2 (ja) 2002-06-04
PT626961E (pt) 2000-10-31
NZ246940A (en) 1996-06-25
EP0984008A3 (en) 2000-05-03
EP0626961B1 (en) 2000-07-05
DE69328962T2 (de) 2000-12-28
KR100261530B1 (ko) 2000-08-01
CA2131019A1 (en) 1993-08-21
DE69328962D1 (de) 2000-08-10
CA2131019C (en) 2002-12-24

Similar Documents

Publication Publication Date Title
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
HK1012366A1 (en) Process for the preparation of cyano-methoxyiminomethyl derivatives
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
IL101012A0 (en) Pyranyl cyanoguanadine derivatives,processes for the preparation thereof and cardioplegic solution containing the same
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
AU7266291A (en) A novel substituted-amine compound and a process for the preparation thereof
GR3020190T3 (en) Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it
IE820239L (en) Carbapenem derivatives
EP0855398A4 (en) SESQUITERPEN DERIVATIVES WITH ANTIVITAL ACTIVITY
EP0374410A3 (en) 2-Azabicyclo[2.2.1]hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of N-phosphonomethylglycine
GB2272218B (en) Process for the preparation of 2,4,6-triiodo-isophthalic acid bis-(1,3-dihydroxypropylamide) derivatives
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them
TW265342B (xx)
GB8707200D0 (en) Chemical process
EP0177728A3 (en) Arphamenine derivatives, a process for their preparation and their use as medicament

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050211